News and Announcements
YPB commences supply to Chinese table salt packaging industry
- Published July 15, 2015 10:15AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th July 2015, ASX Announcement
Highlights:
- YPB supplying invisible tracer and scanners for the protection of up to one billion salt packages for China National Salt Industry Corporation (CNSIC)
- A$325,000 per annum potential revenue
- Approximately 126 million labels already completed
Anti-counterfeiting technology company YPB Group Limited (ASX:YPB) (“YPB, the Company”) has commenced supply of its tracer technology to China’s largest salt label printing company with an initial focus on provincial table salt manufacturers.
Under the supply contarct with the label printing Company on behalf of China National Salt Industry Corporation (CNSIC) one billion labels will be printed with YPB’s anti-counterfeiting technology per annum. To date YPB has already has already completed 126 million labels.
YPB estimates potential revenue from the contract to be A$325,000 per annum and it expects to reach this in CY2016. In addition, the Company expects this supply contract will run for three (3) years.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
